Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
(3S,7S,12R,26R,29R)-29-((4-(di-tert-butylfluorosilyl)benzamido)methyl)-5,10,17,20,28,31-hexaoxo-33-(4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododecan-1-yl)-4-oxa-6,11,16,21,27,30-hexaazatritriacontane-1,3,7,12,26,33-hexacarboxylic acid
ID: ALA5277672
Chembl Id: CHEMBL5277672
Max Phase: Preclinical
Molecular Formula: C62H96FN11O26Si
Molecular Weight: 1458.59
Associated Items: